- Home
- Psychology
- Neuropsychology
- Ketamine
Ketamine
List Price:
$16.95
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Bita Moghaddam
Series:
The MIT Press Essential Knowledge series
Format:
Paperback
Pages:
208
Publisher:
MIT Press (February 16, 2021)
Language:
English
ISBN-13:
9780262542241
ISBN-10:
0262542242
Weight:
5.6oz
Dimensions:
5" x 7" x 0.56"
Case Pack:
50
File:
RandomHouse-PRH_Book_Company_PRH_PRT_Onix_full_active_D20260705T120657_156890284-20260705.xml
Folder:
RandomHouse
List Price:
$16.95
As low as:
$13.05
Publisher Identifier:
P-RH
Discount Code:
A
QuickShip:
Yes
Audience:
General/trade
Country of Origin:
United States
Pub Discount:
65
Imprint:
The MIT Press
Overview
The emergence of ketamine--previously known as a Vietnam-era combat anesthetic and popular 1980s club drug--as a treatment for depression.
Ketamine, approved in May 2019 by the Food and Drug Administration for the treatment of depression, has been touted by both scientists and media reports as something like a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years--in previous incarnations, a Vietnam-era combat anesthetic and popular 1980s club drug--and has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.
Ketamine, approved in May 2019 by the Food and Drug Administration for the treatment of depression, has been touted by both scientists and media reports as something like a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years--in previous incarnations, a Vietnam-era combat anesthetic and popular 1980s club drug--and has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.
